May 16, 2018 Syros to Present on Design of Ongoing Phase 1 Clinical Trial of SY-1365 at Upcoming ASCO Annual Meeting
May 10, 2018 Syros Reports First Quarter 2018 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
Apr 16, 2018 Syros Announces New Preclinical Data on SY-1365 Showing Potent Anti-Tumor Activity in Multiple Models of Heavily Pretreated Ovarian Cancer
Mar 14, 2018 Syros to Present New Preclinical Data on SY-1365 in Ovarian Cancer at Upcoming AACR Annual Meeting
Mar 12, 2018 Syros Reports Fourth Quarter and Full Year 2017 Financial Results and Highlights Recent Accomplishments and Anticipated Milestones
Feb 7, 2018 Syros Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
